QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Second Quantify Research newsletter of 2014 released
The second Quantify Research newsletter of 2014 has been released. The newsletter discusses developments and trends in value-based reimbursement, oncology, initiatives in access to drugs, and more. Details on Quantify Research’s presence at the upcoming ISPOR European congress in Amsterdam are also provided.
Quantify Research at the ISPOR 17th Annual European Congress
Quantify Research will have a large representation at the ISPOR 17th Annual European Congress, to be held in Amsterdam between the 8th and 12th of November. The Quantify Research team will be presenting work within the fields of osteoporosis, cardiovascular disease, and rheumatoid arthritis. More information on the conference is available here.
Quantify Research welcome Audun Ohna to the team
2014-09-15
Quantify Research are delighted to welcome Audun Ohna to the team. Audun will be heading the newly established Oncology department. Welcome Audun!
Study co-authored by Anders Gustavsson estimates the cost of brain disorders in Spain at 84 billion Euro annually
A newly published study co-authored by Anders Gustavsson estimates the cost of brain disorders in Spain at 84 billion Euro annually. This corresponds to 8% of GDP and again shows that brain disorders presents a great societal challenge. Pubmed link